Clinical Rheumatology, 2026 Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjögren’s syndrome to total risk non-Hodgkin lymphoma Wang H., Yan H., Yang M. et al. Olink Target 96OncologyImmunological & Inflammatory DiseasesPathophysiologyPlasma | | | | |
Cardiovascular Research, 2026 miR-146a-5p mediates atherogenic signalling from immune to vascular cells Climent M., Zani S., Salvarani N. et al. Olink Target 96 MouseT48 MouseCVDPathophysiologyMouse Serum | | | | |
HemaSphere, 2026 Preinfusion risk factors for the development of severe neurotoxicity following CART therapy in pediatric patients Diorio C., Myers R., Li Y. et al. Olink Target 96OncologyImmunotherapyPatient StratificationSerum | | | | |
Metabolism, 2026 When the proteome meets the metabolome observational and Mendelian randomization analyses Zheng R., Delgado-Velandia M., Ärnlöv J. et al. Olink Target 96Olink Explore 3072/384Wider Proteomics StudiesPathophysiologyPlasma | | | | |
CNS Neuroscience & Therapeutics, 2026 Olink Proteomics Reveals
CCL2
Aggravates Perihematomal Edema After Intracerebral Hemorrhage in High‐Altitude Migrants Via
CCR2
/
NF
‐
κB
‐Mediated Blood–Brain Barrier Disruption Huang R., Gao L., Dai Y. et al. Olink Target 96Neurovascular DiseasesEnvironmental Health & ToxicologyPathophysiologyPlasma | | | | |
Open Forum Infectious Diseases, 2026 Proteomic Profile After Intervention With Eplerenone Among Persons With HIV Murthy A., Kolossváry M., Walpert A. et al. Olink Target 96CVDInfectious DiseasesPathophysiologyPlasma | | | | |
Pulmonology, 2026 Plasma proteomic signatures linking preserved ratio impaired spirometry to cardiometabolic diseases and multimorbidity: A longitudinal cohort study He L., Liu C., Zhao H. et al. Olink Explore 3072/384Respiratory DiseasesPatient StratificationPlasma | | | | |
Circulation: Genomic and Precision Medicine, 2026 Associations of the
ICAM1
p.K56M HFpEF Risk Variant With Pericardial Adiposity and the Inflammatory Proteome Aneja A., Culler K., Ding J. et al. Olink Target 96Metabolic DiseasesCVDPathophysiologyPlasma | | | | |
Frontiers in Immunology, 2026 Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia Wang J., Pan S., Xiong C. et al. Olink Target 96OncologyImmunotherapyPatient StratificationPlasma | | | | |
Clinical & Experimental Allergy, 2026 Effects of Common Food Additives Kappa‐, Iota‐ and Lambda‐Carrageenans on Intestinal Epithelial Cell Activation and Barrier Disruption Sun N., Pat Y., Babayev H. et al. Olink Target 96Environmental Health & ToxicologyNutritional SciencePathophysiologyOrganoid Culture Medium | | | | |
British Journal of Cancer, 2026 Significance of tumor infiltrating granulocytes and neutrophil extracellular traps in colorectal cancer Rahkola O., Tuomisto A., Elomaa H. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Journal of Proteome Research, 2026 Stability-Based Machine Learning Identifies a Minimal Two-Protein Serum Signature for Early Silicosis Chu X., Li Y., Wang F. et al. Olink Target 96Respiratory DiseasesEnvironmental Health & ToxicologyPatient StratificationSerum | | | | |
Translational Psychiatry, 2026 Plasma proteome profiling identifies novel biomarkers and predictors for schizophrenia Wu S., Guo X., Jia T. et al. Olink Explore 3072/384NeurologyPatient StratificationPlasma | | | | |
Aging Cell, 2026 Plasma Proteomic Profiling of Young and Older Adults Identifies Candidate Biomarkers of Biological Aging at the Intersection of Age and Disease Tavenier J., Holm N., Kallemose T. et al. Olink Explore HTAgingPatient StratificationPlasma | | | | |
Medicine, 2026 Association of genetically determined plasma hepatocyte growth factor with lung cancer and its subtypes: Mendelian randomization and mediation analysis Xu F., Xu Q., Yu J. et al. Olink Target 96OncologyPathophysiologyPlasma | | | | |
Journal of Alzheimer's Disease Reports, 2026 Exploring potential genetic correlation and causality between cathepsins and neurodegenerative diseases: Insight from Mendelian randomization analyses Shu H., He R., Zhu Z. et al. Olink Target 96NeurologyPathophysiologyPlasma | | | | |
Signal Transduction and Targeted Therapy, 2026 Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigation Lambertucci F., Motiño O., Nogueira-Recalde U. et al. Olink Target 48 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Plasma | | | | |
European Journal of Applied Physiology, 2026 Acute responses of inflammatory markers, glucose, and myoglobin in blood following neuromuscular electrical stimulation Flodin J., Amiri P., Reitzner S. et al. Olink Target 96Metabolic DiseasesImmunological & Inflammatory DiseasesTechnical EvaluationBlood | | | | |
Nature Communications, 2026 Macrophage Gsα promotes NLRP3 stability and its intervention attenuates abdominal aortic aneurysm in male mice He L., Qin X., Ren Q. et al. Olink Target 48 MouseCVDPathophysiologyMouse Tissue Lysate | | | | |
The Journal of Headache and Pain, 2026 Plasma proteomics identifies proteins and pathways associated with incident migraine in 50,668 adults Hong Y., Chen F., Mi Y. et al. Olink Explore 3072/384NeurologyPathophysiologyPatient StratificationPlasma | | | | |